Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D N Fass

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
The International Journal of Biochemistry|January 1, 1988
The isolation, characterization and amino terminal sequence of the vitamin D-binding protein (group specific component) from mouse plasmaJ L Borke, R D Litwiller, M P Bell, et al.
The Journal of Clinical Investigation|March 1, 1978
Resistance to arteriosclerosis in pigs with von Willebrand's disease. Spontaneous and high cholesterol diet-induced arteriosclerosisW Fuster, E J Bowie, J C Lewis, et al.
Mayo Clinic Proceedings|June 1, 1979
Hypofibrinogenemia-dysfibrinogenemia and von Willebrand's disease in the same familyC A Owen, E J Bowie, D N Fass, et al.
Journal of Thrombosis and Haemostasis : JTH|August 31, 2004
Atrial fibrillation and thrombosis: immunohistochemical differences between in situ and embolized thrombiW E Wysokinski, W G Owen, D N Fass, et al.
Anesthesia and Analgesia|July 27, 2000
Plasma aprotinin concentrations during cardiac surgery: full- versus half-dose regimensS M Beath, G A Nuttall, D N Fass, et al.
Journal of Immunological Methods|June 9, 1998
Capture-ELISA based on recombinant PR3 is sensitive for PR3-ANCA testing and allows detection of PR3 and PR3-ANCA/PR3 immunecomplexesJ Sun, D N Fass, J A Hudson, et al.
Clinical and Experimental Immunology|November 20, 1998
A proportion of proteinase 3 (PR3)-specific anti-neutrophil cytoplasmic antibodies (ANCA) only react with PR3 after cleavage of its N-terminal activation dipeptideJ Sun, D N Fass, M A Viss, et al.
The Journal of Biological Chemistry|September 25, 1991
The effect of plasma von Willebrand factor on the binding of human factor VIII to thrombin-activated human plateletsM Nesheim, D D Pittman, A R Giles, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1977
Cultured aortic endothelial cells from pigs with von Willebrand disease: in vitro model for studying the molecular defect(s) of the diseaseF M Booyse, A J Quarfoot, S Bell, et al.
The Journal of Clinical Investigation|July 1, 1986
Transplantation of normal bone marrow into a pig with severe von Willebrand's diseaseE J Bowie, L A Solberg, D N Fass, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
The International Journal of Biochemistry|January 1, 1988
The isolation, characterization and amino terminal sequence of the vitamin D-binding protein (group specific component) from mouse plasmaJ L Borke, R D Litwiller, M P Bell, et al.
The Journal of Clinical Investigation|March 1, 1978
Resistance to arteriosclerosis in pigs with von Willebrand's disease. Spontaneous and high cholesterol diet-induced arteriosclerosisW Fuster, E J Bowie, J C Lewis, et al.
Mayo Clinic Proceedings|June 1, 1979
Hypofibrinogenemia-dysfibrinogenemia and von Willebrand's disease in the same familyC A Owen, E J Bowie, D N Fass, et al.
Journal of Thrombosis and Haemostasis : JTH|August 31, 2004
Atrial fibrillation and thrombosis: immunohistochemical differences between in situ and embolized thrombiW E Wysokinski, W G Owen, D N Fass, et al.
Anesthesia and Analgesia|July 27, 2000
Plasma aprotinin concentrations during cardiac surgery: full- versus half-dose regimensS M Beath, G A Nuttall, D N Fass, et al.
Journal of Immunological Methods|June 9, 1998
Capture-ELISA based on recombinant PR3 is sensitive for PR3-ANCA testing and allows detection of PR3 and PR3-ANCA/PR3 immunecomplexesJ Sun, D N Fass, J A Hudson, et al.
Clinical and Experimental Immunology|November 20, 1998
A proportion of proteinase 3 (PR3)-specific anti-neutrophil cytoplasmic antibodies (ANCA) only react with PR3 after cleavage of its N-terminal activation dipeptideJ Sun, D N Fass, M A Viss, et al.
The Journal of Biological Chemistry|September 25, 1991
The effect of plasma von Willebrand factor on the binding of human factor VIII to thrombin-activated human plateletsM Nesheim, D D Pittman, A R Giles, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1977
Cultured aortic endothelial cells from pigs with von Willebrand disease: in vitro model for studying the molecular defect(s) of the diseaseF M Booyse, A J Quarfoot, S Bell, et al.
The Journal of Clinical Investigation|July 1, 1986
Transplantation of normal bone marrow into a pig with severe von Willebrand's diseaseE J Bowie, L A Solberg, D N Fass, et al.
Pageof 8